Apollo hospitals script new era in cardiac care
Apollo Hospitals Enterprise Ltd, Asia's largest and most trusted multi-specialty chain of hospitals, recently showcased the group's prowess in cardiac care in the largest cohort of cases treated with advanced cardiac interventional methods. These include three key innovations – MitraClip, TAVI (Trans-catheter Aortic Valve Implantation) or TAVR (Trans-catheter Aortic Valve Replacement) and MICS CABG or MICAS (Minimally Invasive Coronary Artery Bypass Surgery). Specialists in structural and interventional cardiology at Apollo Hopsitals have successfully performed 6 MitraClip procedures out of the 9 performed in India, over 85 TAVI/TAVRs with excellent clinical outcomes and a nation-leading 1250+ MICS CABGs with superior outcomes at par with international standards, at only 1/2 or 1/3rd the cost compared to global price matrix.
Emphasising Apollo Hospitals' pioneering position in bringing the cutting edge of medical technology to India, Dr Prathap C Reddy, Founder and Chairman, Apollo Hospitals Group said, "Globally, an estimated 17 million people die of cardiovascular disease every year. Today, we have the power of technology and we must harness this to empower us in the battle against this epidemic of heart disease. In line with our mission to bring healthcare of International standards within the reach of every individual, we have also been a pioneer in the field of cardiac care, and it is our constant endeavor to get the latest technology to benefit our patients. We are indeed proud to showcase our achievements in bringing futuristic cardiac care with state of the art medical technology to the country."
Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said, "The need of the hour is to have a robust scientific approach to identify the challenges in India in dealing with the patients affected with cardiac disease. This allows us to work towards a future where cardiovascular care is population-based, weighing cost and outcomes, but individually tailored and thoroughly coordinated around patients. Today, the role of technology in healthcare is as inseparable as a shadow to a body. Our services are designed to give more control, choices, and knowledge to patients. With our prowess in harnessing cutting edge technology, we at Apollo Hospitals are committed to deliver best in cardiac care to our patients in India and around the globe"
Elaborating on the modern techniques in interventional cardiology, Dr Sai Satish, Senior Interventional Cardiologist, Apollo Hospitals said, "Apollo Hospitals is constantly striving to bring the latest advanced therapies for patients in India. These include the newer structural interventions including MitraClip and TAVI/TAVR which allow many patients with severe cardiac risks who cannot undergo surgery to benefit from minimally invasive therapies."
Dr Sengottuvelu G., Senior Consultant and Interventional Cardiologist said, "Apollo Hospitals is constantly striving to bring the latest advanced therapies for patients in India and is uniquely placed as the academic TAVR centre of excellence with many milestone achievements. Transcatheter Aortic Valve Replacement (TAVR), also known as Transcatheter Aortic Valve Implantation (TAVI) is the most cutting edge procedure being conducted at Apollo Hospitals, and allows a cardiologist to replace a malfunctioning valve in a patient's heart in a minimally invasive procedure without cutting open the chest. It is a promising alternative to open heart surgery."
Dr Srinivas Kumar A, Cardiologist, Apollo Hospitals, Hyderabad and Director of National Interventional Council said, "Today, the Apollo group of hospitals are leading the nation in undertaking highest number of Coronary Interventions in India; With 29 Cathlab facilities and 300+ Cardiovascular clinicians, Apollo Hospital is well-positioned to enhance their service offering across the country."
Dr Sathyaki P Nambala, Senior Consultant, Cardio-Thoracic and Vascular Surgery said, "MCIS requires advanced training and besides Apollo Hospitals, there are only a handful of centers all over the world that are capable of performing MICS safely. Going forward, we aim to train more surgeons to make this treatment option available for the patients everywhere."
